Ten Reasons Systematic Reviews and Meta-Analyses May Harm Surgical Literature

Systematic reviews and meta-analyses have traditionally occupied the top tiers of the evidence hierarchy, serving as critical tools for synthesizing clinical data. Yet, the unique characteristics of surgical practice—ranging from operator variability to institutional diversity—challenge the assumption that such methodologies always yield reliable conclusions.1 This editorial presents 10 reasons why the overuse or misapplication of systematic reviews and meta-analyses may be detrimental to the field of surgery, with implications for journal editorial standards, clinical guidelines, and policy. 1. OVERSIMPLIFICATION OF COMPLEX SURGICAL REALITIES Surgery is inherently complex and variable. Factors such as surgeon skill, experience, and intraoperative judgment significantly affect outcomes, as do patient-specific anatomic and physiological differences. Systematic reviews, by design, aim to homogenize data for comparison. In doing so, they often oversimplify and ignore the nuanced realities of surgical interventions. This may result in conclusions that are not only misleading but also potentially harmful if applied universally in clinical practice without consideration of context.2,3 2. INCLUSION OF LOW-QUALITY EVIDENCE To meet statistical requirements for inclusion, many systematic reviews incorporate studies with suboptimal methodology, small sample sizes, or high bias risk. In the context of surgery, where randomized controlled trials are already challenging to conduct, the temptation to include lower-tier evidence becomes particularly strong.1 The synthesis of such studies can create a false sense of certainty, with meta-analyses potentially producing spurious results that mask the true variability and uncertainty in the data.4,5 Although labeled as level II evidence, many surgical meta-analyses exemplify the limitations of relying on heterogeneous and methodologically weak primary studies. For instance, the 2022 meta-analysis comparing arthroscopic-assisted versus fluoroscopic volar plating for distal radius fractures synthesized only 6 small studies—4 of which were retrospective—characterized by substantial variability in surgical technique, inconsistent reporting of patient and fracture characteristics, and statistically significant heterogeneity in key outcomes.6 The authors themselves acknowledge risks of publication bias, limited sample sizes, and inconsistent outcome measurement, all of which undermine the strength of the pooled conclusions. This illustrates how meta-analyses in surgery may present an illusion of high-level evidence while in fact being constrained by the poor quality and inconsistency of the underlying data. 3. BIAS AGAINST INNOVATION Surgical innovation is a continual process that often begins with small case series or single-center studies before broader validation. These early-stage innovations typically lack the volume of literature necessary for inclusion in systematic reviews. As a result, systematic reviews inherently favor established procedures, reinforcing the status quo and creating barriers to the dissemination and adoption of novel techniques. This lag in evidence representation may delay the clinical application of potentially life altering surgical advancements.3,7 4. PROLIFERATION OF REDUNDANT PUBLICATIONS The relative ease of conducting systematic reviews compared with original research has contributed to a significant increase in their publication. Regrettably, many of these reviews are redundant, providing limited novel insights or lacking a critical appraisal of the included literature. This proliferation of repetitive reviews can overwhelm readers, diminish the impact of meaningful findings, and clutter the scientific literature with noise that obscures high-quality, practice-changing evidence. In upper-limb surgery, evidence synthesis is excessively redundant. A PubMed search revealed hundreds of systematic reviews and meta-analyses on interventions for the hand, wrist, forearm, peripheral nerves, and brachial plexus, often reanalyzing small, heterogeneous primary studies. From 2020 to 2025, 181 such publications appeared in the Journal of Hand Surgery, American, European, and HAND. Many reviews overlap on topics such as distal radius fractures, reaching similar conclusions. The literature on nerve repair and transfer strategies is similarly saturated, despite limited data. This reflects a key issue: meta-analyses are easier to produce than high-quality studies, leading to numerous publications that focus on seeming evidence rather than substantive quality. Currently, the prevailing trend favors reassessment over innovation. While this approach may enhance one’s curriculum vitae, it is less effective for fostering advancement and innovation within the field. 5. RIGID INFLUENCE ON CLINICAL GUIDELINES Clinical guidelines heavily rely on systematic reviews and meta-analyses to formulate standardized recommendations. While this may streamline care, it can also lead to rigid protocols that overlook individual patient factors, surgeon discretion, and evolving practices. The reliance on reviews that may not account for real-world surgical complexity risks codifying flawed or outdated practices into policy, limiting flexibility, and potentially compromising patient outcomes.2,8 6. MISALIGNMENT WITH REIMBURSEMENT AND POLICY DECISIONS Systematic reviews often inform policy decisions related to procedure reimbursement, approval, and resource allocation. If these reviews are based on incomplete or low-quality data, the resulting policies may hinder access to beneficial procedures or inadvertently promote inferior techniques. This misalignment between policy and clinical reality can have widespread negative implications for patient care and surgical innovation.8 7. ACADEMIC INCENTIVIZATION AND SHORTCUTS The explosive rise in systematic reviews and meta-analyses is not merely a reflection of scientific need—it is tightly linked to academic incentives. Between 2000 and 2016, the annual number of systematic reviews indexed in PubMed increased more than 20-fold, from roughly 2000 to over 25,000 per year, far outpacing the growth of original clinical research.1,7,9 Ioannidis famously described this surge as a “mass production of redundant, conflicted, and often misleading reviews,” noting that more than half of published meta-analyses address clinical questions already covered by prior reviews, often recycling the exact same primary studies.1 These pressures are especially magnified in surgery, where high-quality prospective trials are difficult, expensive, and slow to conduct. As a result, systematic reviews—requiring only database access, basic statistical tools, and adherence to PRISMA checklists—have become a convenient academic currency. Studies evaluating authorship patterns reveal that trainees or early-career researchers contribute a substantial proportion of surgical systematic reviews, often without domain-specific expertise, and are motivated primarily by the need for promotable publications.9 Agha and Fowler7 reported that only 34% of the surgical meta-analyses they assessed met accepted standards for methodological rigor, and fewer than 20% altered clinical understanding in a meaningful way. This incentive structure fosters a cycle in which publication counts increase while scientific value stagnates. Editorial boards are inundated with reviews that offer little novelty, minimal critical evaluation, and no new clinical insight. As reviews accumulate, they amplify the perceived strength of weak underlying evidence rather than improving it. Over time, this proliferation risks eroding trust in systematic reviews as reliable, high-level evidence within the surgical community. The academic reward system, by emphasizing quantity over meaningful contribution, thus unintentionally promotes repetition over innovation and diverts researcher effort away from prospective studies, registries, and methodological improvements that could genuinely advance surgical care. 8. LIMITED INPUT FROM SURGICAL EXPERTS Systematic reviews are frequently authored by individuals with limited surgical training or hands-on experience. This lack of domain-specific expertise can result in misinterpretation of surgical techniques, misclassification of procedures, or inadequate evaluation of critical variables such as operative difficulty, patient selection, and postoperative management. Reviews lacking surgical insight may produce conclusions that are disconnected from practical, real-world application.7 9. PERPETUATION OF FLAWED EVIDENCE CYCLES By drawing on prior literature without rigorous reassessment, systematic reviews can inadvertently perpetuate outdated or incorrect findings. When multiple reviews reference the same flawed primary studies or earlier meta-analyses, they reinforce misconceptions and distort the evidence base. This recursive cycle undermines scientific progress and can entrench practices that are no longer supported by the best available evidence.10 10. DIVERSION OF RESOURCES FROM HIGH-VALUE RESEARCH Surgical journals and research institutions operate within limited budgets and editorial bandwidth. The prioritization of systematic reviews, particularly low-impact ones, consumes space and attention that could be allocated to more valuable forms of evidence, such as prospective trials, registries, and qualitative studies. These alternative methodologies are often better suited to capture the complexity of surgical care and generate actionable insights for clinical improvement.11 CONCLUSION Systematic reviews and meta-analyses have a place in surgical research, but their limitations must be clearly understood. When built on small, heterogeneous, or methodologically weak primary studies—as is common in surgery—these analyses can distort rather than clarify the evidence landscape. Overreliance on such methods risks elevating statistically polished but clinically fragile conclusions, ultimately diminishing the quality and applicability of the surgical literature. A more discerning editorial and academic approach is therefore essential, one that prioritizes methodological rigor, clinical relevance, and the practical realities of operative care over strict adherence to evidence hierarchies developed for nonsurgical disciplines. Importantly, the evidence-tiering framework created for internal medicine or other non-surgical specialties do not translate cleanly to surgery. Although level I studies occupy the top tier, their limitations—outlined here and in prior work12—often diminish their practical utility for practicing surgeons. In many situations, the nuanced insight gained from a carefully documented case report provides more actionable guidance than the abstracted conclusions of a randomized trial. Likewise, a surgeon’s accumulated experience (level VI)13—which incorporates years of judgment, technical refinement, successes, and failures—can offer a depth of understanding that no pooled analysis can replicate. Surgical decision-making is fundamentally experiential, and our evidence framework should reflect that reality rather than inadvertently marginalize it. Delphi-type consensus statements warrant similar caution.14 Although often presented as authoritative, they represent the perspectives of a selected group rather than the full spectrum of surgical expertise. This inherently introduces selection bias and risks excluding unconventional or emerging approaches—not due to lack of merit, but because they fall outside prevailing familiarity. In surgery, where progress is driven by iterative technical evolution and hands-on experience rather than polling, such limitations must be explicitly acknowledged. Ultimately, improving the quality of surgical evidence requires recognizing the strengths and limits of each methodological tool, valuing diverse forms of clinical insight, and resisting the temptation to mistake syntactic rigor for scientific truth. Only through such a balance can surgical journals cultivate an evidence base that meaningfully advances patient care and supports genuine innovation within the field.